Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0649-2021

Drug recall · July 14, 2021

Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg recall

Why: Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvogen, Inc. Pine Brook, NJ 07058 USA, NDC 47781-355-03

Lots / codes

Lot #: 36924, Exp 6/2021

Quantity
9,696 cartons
Company
Alvogen, Inc, Morristown, NJ
Distribution
USA nationwide.
Initiated
February 26, 2021 · Voluntary: Firm initiated
Classified
July 2, 2021
Reported
July 14, 2021
Ended
February 16, 2022
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Buprenorphine / naloxone

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.